Chemical Structure : ACLY inhibitor VCB1
货号: PC-28484Not For Human Use, Lab Use Only.
ACLY inhibitor VCB1 is a potent, small molecule ATP citrate lyase (ACLY) inhibitor with IC50 of 0.9 uM, strongly suppresses lymphoma cell growth.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ACLY inhibitor VCB1 is a potent, small molecule ATP citrate lyase (ACLY) inhibitor with IC50 of 0.9 uM, strongly suppresses lymphoma cell growth.
VCB1 shows an IC50 of 0.299 μM and retains potency in lorlatinib-resistant SUPM2-LR1000 cells (1.62 μM).
VCB1 inhibits BTK inhibitor sensitive and resistant mantle cell lymphoma cell growth (IC50, 0.28 and 0.278 μM).
VCB1 activates the integrated stress response (ISR), inducing ATF4, PPP1R15A, DDIT3, DDIT4 and SESN2, while disrupting purine and pyrimidine metabolism and reducing nucleotide biosynthetic genes, including CAD, DHODH, UCK2, and ATIC.
VCB1 also alters immune-regulatory programs involving PDCD1, TIGIT, CD247, CD226, NFATC2, and inflammatory cytokines.
VCB1 induces cell cycle arrest and apoptosis across TKI-sensitive and resistant lymphoma models.
| 分子量 | 467.31 | |
| 分子式 | C22H16Cl2N6O2 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Pattabiraman N, et al. bioRxiv [Preprint]. 2026 Oct 4:2026.09.29.755331.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright